Metrics
Publication
279
Open Access
32
UN Sustainable Development Goals
Announcements & Documents
Download File
Education
2006 - 2010
2006 - 2010Post Doctorate of Medicine
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1997 - 2006
1997 - 2006Expertise In Medicine
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1991 - 1997
1991 - 1997Undergraduate
Ankara University, Tıp Pr., Turkey
Dissertations
2010
2010Post Doctorate of Medicine
Mültipl myelomda yüksek doz kemoterapi ve otolog hematopoetik kök hücre nakli ile tedavide serum serbest hafif zincir düzeylerinin prognostik anlamı
Gazi University, Tıp Fakültesi
2002
2002Expertise In Medicine
Diyaliz tedavisi alan hastalarda aterosklerotik risk faktörlerinin karotis aterosklerozu ile korelasyonu
Gazi University, Tıp Fakültesi
Research Areas
Health Sciences
Academic Positions
2018 - Present
2018 - PresentProfessor
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2012 - 2018
2012 - 2018Associate Professor
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2009 - 2010
2009 - 2010Lecturer
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2006 - 2009
2006 - 2009Research Assistant PhD
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
2003 - 2006
2003 - 2006Assistant Professor
Kirikkale University, School Of Medıcıne, Department Of Internal Medıcıne
1997 - 2002
1997 - 2002Research Assistant PhD
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
Managerial Experience
2013 - Present
2013 - PresentFarabi Program Institutional Coordinator
Gazi University, Tıp Fakültesi
2022 - 2025
2022 - 2025Head of Department
Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri
Non Academic Experience
2010 - 2012
2010 - 2012HEMATOLOJİ UZMANI
KAHRAMANMARAŞ DEVLET HASTANESİ, HEMATOLOJİ UZMANI
2002 - 2003
2002 - 2003İÇ HASTALIKLARI UZMANI
MİLLİ EĞİTİM BAKANLIĞI BEŞEVLER SAĞLIK EĞİTİM MERKEZİ, İÇ HASTALIKLARI UZMANI
Supervised Theses
2024
2024Expertise In Medicine
Multipl Miyelom Tanılı Hastalarda Ekstramedüller Hastalık Tutulumunun Prognoz ve Sağkalım Üzerine Etkisinin Değerlendirilmesi
Özkurt Z. N. (Consultant)
S.KANBER(Student)
2023
2023Expertise In Medicine
Allojenik kök hücre nakli yapılan hastalarda steroide yanıtsız gastrointestinal graft versus host hastalığı risk faktörlerinin belirlenmesi ve tedavi seçeneklerinin değerlendirilmesi
Özkurt Z. N. (Consultant)
K.TALAY(Student)
2022
2022Expertise In Medicine
Akut lösemi tanılı allojenik kök hücre nakli yapılan hastalarda hepatik veno-okluzif hastalık sıklığı ve risk faktörleri
Özkurt Z. N. (Consultant)
E.AREL(Student)
2020
2020Expertise In Medicine
Yeni tanı multipl myelomlu hastalarda indüksiyon tedavisi ile değişen performans, geriatrik değerlendirme ve kırılganlık testi sonuçlarının analizi
ÖZKURT Z. N. (Consultant)
K.DURMUŞ(Student)
2019
2019Expertise In Medicine
The Effect Of Comorbidity Scores And Geriatric Tests On The Results Of Autologous Stem Cell Transplantation Recipients
Özkurt Z. N. (Consultant)
M.KESTANE(Student)
2018
2018Expertise In Medicine
Toxicity of maintenance therapy in adult Acute Lymphoblastic Leucemia and evaluating effect of toxicity on survival outcomes, Gazi University Faculty of Medicine, Thesis in Internal Medicine
Özkurt Z. N. (Consultant)
M.ECEM(Student)
2015
2015Expertise In Medicine
Analysis of The Factors Associated With Mobilization Success in Allogeneic Stem Cell Donors
ÖZKURT Z. N. (Consultant)
L.BATMAZ(Student)
Articles
All (123)
SCI-E, SSCI, AHCI (99)
SCI-E, SSCI, AHCI, ESCI (108)
ESCI (7)
Scopus (106)
TRDizin (32)
Other Publications (1)
2025
20251. C-Reactive Protein/Albumin Ratio (CAR) Predicts Early Posttransplant Complications and Survival in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
YILDIZ Ş., YEGİN Z. A., GÜNDEM G. G., Yaşar S., Çiçekli S., ÖZKURT Z. N., et al.
Indian Journal of Hematology and Blood Transfusion
, vol.41, no.4, pp.800-808, 2025 (SCI-Expanded)
2024
20242. Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma
Ozturk H., Dikyar A., YEGİN Z. A., Kaynar L., Can F., ÖZKURT Z. N.
NIGERIAN JOURNAL OF CLINICAL PRACTICE
, vol.27, no.12, pp.1405-1409, 2024 (SCI-Expanded)
2024
20243. Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Salas M. Q., Eikema D., Koster L., Maertens J., Passweg J., Finke J., et al.
BONE MARROW TRANSPLANTATION
, vol.59, no.4, pp.479-488, 2024 (SCI-Expanded)
2024
20244. Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Savaş E. M., Yegin Z. A., Kök M. İ., Karayel H. T., Özkurt Z. N., Bozer M. N., et al.
Transplantation proceedings
, vol.56, no.2, pp.386-393, 2024 (SCI-Expanded)
2024
20245. Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Battipaglia G., Labopin M., Mielke S., Ruggeri A., Nur Ozkurt Z. N., Bourhis J. H., et al.
Transplantation and Cellular Therapy
, vol.30, no.1, 2024 (SCI-Expanded)
2024
20246. Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.
Bostankolu Değirmenci B., Yegin Z. A., Akdemir Ü. Ö., Dede A., Gündem G. G., Özkurt Z. N., et al.
Annals of hematology
, vol.103, no.1, pp.269-283, 2024 (SCI-Expanded)
2024
20247. Ototoxicity associated with hematopoietic stem cell transplantation; what are the risk factors?
Uzunoglu E., Akalın M., Özkurt Z. N., Yegin Z. A., Karamert R.
ACTA OTO-LARYNGOLOGICA
, vol.144, no.11-12, pp.615-619, 2024 (SCI-Expanded)
2023
20238. ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O., Peczynski C., Boreland W., Lemaitre J., Afanasyeva K., Kornblit B., et al.
Frontiers in immunology
, vol.14, pp.1283034, 2023 (SCI-Expanded)
2023
20239. Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study.
Savaş E. M., Yılmaz S., Başer Dikyar A. A., Özkurt Z. N., Öcal R., Can F., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.40, no.4, pp.236-241, 2023 (SCI-Expanded)
2023
202310. Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
YEGİN Z. A., SAVAŞ E. M., YILDIZ Ş., KÖK M. İ., ERDEMİR M. B., BOSTANKOLU DEĞİRMENCİ B., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.39, no.4, pp.586-597, 2023 (SCI-Expanded)
2023
202311. The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients
Kaynar L. A., Oezkurt Z. N.
CUREUS JOURNAL OF MEDICAL SCIENCE
, vol.15, no.9, 2023 (ESCI)
2023
202312. Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort.
Kaynar L. A., Özkurt Z. N., Savaş E. M., Yeğin Z. A., Göçün P. U., Akyürek N., et al.
Leukemia research
, vol.131, pp.107332, 2023 (SCI-Expanded)
2023
202313. Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients
Gunes E. K., ÖZKURT Z. N., YILDIZ Ş., Ozet G., Ceran F., Albayrak M., et al.
LEUKEMIA RESEARCH
, vol.128, 2023 (SCI-Expanded)
2023
202314. Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT
Waszczuk-Gajda A., Gras L., de Wreede L. C., Sirait T., Illes A., ÖZKURT Z. N., et al.
BONE MARROW TRANSPLANTATION
, vol.58, no.4, pp.424-429, 2023 (SCI-Expanded)
2023
202315. The Turkish perspective on apheresis activity: The Turkish apheresis registry report
Ozatli D., Giden A. O., ERKURT M. A., Korkmaz S., Basci S., Ulas T., et al.
Transfusion and Apheresis Science
, vol.62, no.2, 2023 (SCI-Expanded)
2023
202316. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
Çuhadar T., Kalkancı A., Tunçcan Güzel Ö., Yeğin Z. A., Özkurt Z. N., Köktürk N., et al.
Mikrobiyoloji bulteni
, vol.57, no.2, pp.274-282, 2023 (SCI-Expanded)
2023
202317. Analysis of bone marrow samples by the SYSMEX-XN20 hematology analyzer
KAYA Z., Kirkiz S., ÖZKURT Z. N., YAĞCI A. M., KOÇAK Ü.
International Journal of Laboratory Hematology
, vol.45, no.2, 2023 (SCI-Expanded)
2023
202318. Effects of COVID-19 Infection on Patients with Hematological Malignancy
KAYNAR L. A., GÜZEL F. Ö., Dikyar A., Bostankolu Değirmenci B., BOZDAYI G., ERBAŞ G., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.7, no.1, pp.14-19, 2023 (Peer-Reviewed Journal)
2023
202319. COVID-19 Enfeksiyonunun Hematolojik Maligniteli Hastalar Üzerine Etkiler
AYDIN KAYNAR L., GÜZEL TUNÇCAN Ö., DİKYAR A., BOSTANKOLU DEĞİRMENCİ B., BOZDAYI G., ERBAŞ G., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.7, no.1, pp.14-19, 2023 (Peer-Reviewed Journal)
2023
202320. Salvage autologous hematopoietic stem cell transplantation versus chemoimmunotherapy in relapsed multiple myeloma patients after first transplantation, single center data
CAN F., ÖZKURT Z. N., ÖCAL R., YEGİN Z. A., AYDIN KAYNAR L., YAĞCI A. M.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.76, no.3, pp.200-205, 2023 (Peer-Reviewed Journal)
2023
202321. Opioid Administration for Mucositis-related-Pain Using Patient Controlled Analgesia (PCA) Method is Associated with the Development of Early Posttransplant Complications
gürün k., YEGİN Z. A., Akçalı D., ÖZKURT Z. N., tertemiz o., CAN F., et al.
ACTA ONCOLOGICA TURCICA
, vol.56, no.2, pp.125-135, 2023 (Peer-Reviewed Journal)
2023
202322. Exercise capacity, physical activity and quality of life in patients with newly diagnosed hematologic malignancies: a cross-sectional study
ÇELİK Z., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N.
PHYSIOTHERAPY THEORY AND PRACTICE
, vol.39, no.6, pp.1152-1162, 2023 (SCI-Expanded, Scopus)
2023
202323. Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
AYGENCEL BIKMAZ Ş. G., Gökçe O., Haşimoğlu M., BOYACI DÜNDAR N., TÜRKOĞLU M., YEGİN Z. A., et al.
Turkish Journal of Medical Sciences
, vol.53, no.1, pp.340-351, 2023 (SCI-Expanded)
2022
202224. Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis
Demirel K. D., ÖZKURT Z. N., Dogrul R. T., Kaynar L. A., YEGİN Z. A., GÖKER B., et al.
ANNALS OF HEMATOLOGY
, vol.101, no.12, pp.2691-2697, 2022 (SCI-Expanded)
2022
202225. The impact of thrombopoietin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplant recipients
Degirmenci B. B., Yegin Z. A., Dikyar A., Kaynar L. A., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
BONE MARROW TRANSPLANTATION
, vol.57, no.SUPPL 1, pp.362-363, 2022 (SCI-Expanded)
2022
202226. Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A., Labopin M., Swoboda R., Pioltelli P., Arat M., Yakoub-Agha I., et al.
HemaSphere
, vol.6, no.11, 2022 (Scopus)
2022
202227. Maintenance Therapy Toxicities, MTHFR and TPMT Genetic Polymorphism Analysis, and the Effect of Dose Manipulations on Survival Outcomes in Adult Patients with Turkish Acute Lymphoblastic Leukemia
Erdoğan Yön M. E., Özkurt Z. N., Gökçen S., Öcal R., Yegin Z. A., Yağcı A. M.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.6, no.2, pp.29-37, 2022 (Peer-Reviewed Journal)
2022
202228. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia
BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
Leukemia Research
, vol.118, 2022 (SCI-Expanded)
2022
202229. Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia
AYDIN KAYNAR L., GÖKÇEN S., Can F., YEGİN Z. A., ÖZKURT Z. N., Yagci M.
ANNALS OF HEMATOLOGY
, vol.101, no.7, pp.1459-1464, 2022 (SCI-Expanded)
2022
202230. Variable impact of graft CD3(+) cell content on graft versus host disease in hematopoietic stem cell transplant recipients: Is the role of donor CD3(+) cells overestimated?
YEGİN Z. A., BOSTANKOLU DEĞİRMENCİ B., YAZICI ŞENER G., SAVAŞ E. M., ÖZKURT Z. N., Koc H. N., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.61, no.3, 2022 (SCI-Expanded)
2022
202231. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
Drozd-Sokolowska J., Gras L., Zinger N., Snowden J. A., Arat M., Basak G., et al.
BONE MARROW TRANSPLANTATION
, vol.57, no.4, pp.633-640, 2022 (SCI-Expanded)
2022
202232. Standart Prophylactic Granulocyte Colony Stimulating Factor Usage as a Part of Autologous Stem Cell Transplantati̇ on Procedure
AYDIN KAYNAR L., ÖZKURT Z. N., CAN F., YEGİN Z. A., GÜZEL TUNÇCAN Ö., YAĞCI A. M.
ACTA ONCOLOGICA TURCICA
, vol.55, pp.52-57, 2022 (Peer-Reviewed Journal)
2022
202233. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
CİVRİZ BOZDAĞ S., CENGİZ SEVAL G., Hindilerden I. Y., Hindilerden F., ANDIÇ N., BAYDAR M., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.39, no.1, pp.43-54, 2022 (SCI-Expanded)
2021
202134. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
Barlas T., Inci K., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., GÜZEL TUNÇCAN Ö., Can F., et al.
Hematology (Amsterdam, Netherlands)
, vol.26, no.1, pp.328-339, 2021 (SCI-Expanded, Scopus)
2021
202135. Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study
Greenfield D. M., Salooja N., Peczynski C., van der Werf S., Schoemans H., Hill K., et al.
BONE MARROW TRANSPLANTATION
, vol.56, no.11, pp.2820-2825, 2021 (SCI-Expanded)
2021
202136. An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
Sevindik O. G., ÖZKURT Z. N., Boga C., Besisik S. K., Ipek Y., GEDÜK A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.21, 2021 (SCI-Expanded)
2021
202137. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study
Akay O. M., ÖZBALAK M. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
HEMATOLOGICAL ONCOLOGY
, vol.39, no.4, pp.498-505, 2021 (SCI-Expanded)
2021
202138. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
Ozbalak M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.21, 2021 (SCI-Expanded)
2021
202139. Hematopoietic Cell Transplant-Composite Risk (HCT-CR): A Novel Predictor of Prognosis in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
YEGİN Z. A., ÖZKURT Z. N., DİKYAR A., AYDIN KAYNAR L., KARACAOĞLU YURDAGÜL Ö., Yagci M.
TRANSPLANTATION PROCEEDINGS
, vol.53, no.6, pp.2013-2020, 2021 (SCI-Expanded)
2021
202140. Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Sanz J., Labopin M., Sanz M. A., Aljurf M., Sousa A. B., Craddock C., et al.
BONE MARROW TRANSPLANTATION
, vol.56, no.6, pp.1272-1280, 2021 (SCI-Expanded)
2021
202141. Autologous Hematopoietic Cell Transplantation For Relapsed Multiple Myeloma Performed With Stem Cells Re-Mobilised Following A Prior AUTO-HCT - A Retrospective Study on Behalf of EBMT CMWP
Drozd-Sokolowska J., Gras L., Zinger N., Snowden J. A., Arat M., Basak G., et al.
BONE MARROW TRANSPLANTATION
, vol.56, pp.133-134, 2021 (SCI-Expanded)
2021
202142. Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders.
Colak M., Sarzhanova S., Yegin Z. A., Ozkurt Z. N., Fidan I., Bozdayi G.
Clinical lymphoma, myeloma & leukemia
, vol.21, no.5, 2021 (SCI-Expanded)
2021
202143. Retrospective Evaluation of Effects of Preoperative Anaemia Treatment in Gynaecological and Obstetric Surgical Patients
Gunaydin B., Işik G., Bağcaz S., Inan G., Bozkurt N., Özkurt Z. N., et al.
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION
, vol.49, no.1, pp.25-29, 2021 (ESCI)
2021
202144. Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
AYGENCEL BIKMAZ Ş. G., BOYACI DÜNDAR N., TÜRKOĞLU M., YEGİN Z. A., ÖZKURT Z. N., YAĞCI A. M.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.51, no.4, pp.2095-2100, 2021 (SCI-Expanded)
2020
202045. Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
BONE MARROW TRANSPLANTATION
, vol.55, no.9, pp.1763-1772, 2020 (SCI-Expanded)
2020
202046. Retrospective analysis of the association of the expression and single nucleotide polymorphisms (SNPs) of the TLR4, PTX3 and Dectin-1 (CLEC/A) genes with development of invasive aspergillosis among haematopoietic stem cell transplant recipients with oncohaematological disorders
Kalkancı A., Tuğ E., Fidan I., Güzel Tunçcan Ö., Özkurt Z. N., Yegin Z. A., et al.
MYCOSES
, vol.63, pp.832-839, 2020 (SCI-Expanded)
2020
202047. Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
HAEMATOLOGICA
, vol.105, no.7, pp.1977-1983, 2020 (SCI-Expanded)
2020
202048. The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients
YEGİN Z. A., Can F., GÖKÇEN S., Sadioglu R. E., ÖZKURT Z. N., İLHAN Ç., et al.
Balkan medical journal
, vol.37, no.3, pp.138-143, 2020 (SCI-Expanded)
2020
202049. Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
FRONTIERS IN IMMUNOLOGY
, vol.11, 2020 (SCI-Expanded)
2020
202050. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Gonzalez-Barca E., Boumendil A., Blaise D., Trneny M., Masszi T., Finel H., et al.
BONE MARROW TRANSPLANTATION
, vol.55, no.2, pp.393-399, 2020 (SCI-Expanded)
2020
202051. Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients
YEGİN Z. A., Can F., Aydin Kaynar L., GÖKÇEN S., Eren Sadioglu R., ÖZKURT Z. N., et al.
HEMATOLOGY
, vol.25, no.1, pp.125-133, 2020 (SCI-Expanded)
2020
202052. Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
ÇOLAK M., Kocak A. A., Kaynar L. A., ÖZKURT Z. N., YEGİN Z. A., BOZDAYI G.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
, vol.25, no.1, pp.40-46, 2020 (ESCI)
2020
202053. Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
YEGİN Z. A., DİKYAR A., Kaynar L. A., Can F., ÖZKURT Z. N., Yagci M.
HEMATOLOGY REPORTS
, vol.12, no.3, pp.51-54, 2020 (ESCI)
2019
201954. A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Cremers E. M. P., de Witte T., de Wreede L., Eikema D., Koster L., van Biezen A., et al.
LEUKEMIA & LYMPHOMA
, vol.60, no.10, pp.2404-2414, 2019 (SCI-Expanded)
2019
201955. Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
Robin M., Chevret S., Koster L., Wolschke C., Yakoub-Agha I., Bourhis J. H., et al.
HAEMATOLOGICA
, vol.104, no.6, pp.1230-1236, 2019 (SCI-Expanded)
2019
201956. Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia
Mentese I. B., YEGİN Z. A., GÖKÇEN S., ÖZKURT Z. N., Yagci M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.35, no.2, pp.265-271, 2019 (SCI-Expanded)
2018
201857. Tuberculosis reactivation related with ruxolitinib in a patient with primary myelofibrosis
Pepeler M. S., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., AKYÜREK N.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
, vol.12, no.10, pp.926-928, 2018 (SCI-Expanded)
2018
201858. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection
Pepeler M. S., YILDIZ Ş., YEGİN Z. A., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
, vol.12, no.9, pp.799-805, 2018 (SCI-Expanded)
2018
201859. Relationship between Epstein-Barr Virus (EBV) Infection and Viral Load in Immunosuppressive Patients
Colak M., Kocak A. A., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
ISTANBUL MEDICAL JOURNAL
, vol.19, no.1, pp.7-13, 2018 (ESCI)
2018
201860. Monoclonal B-cell lymphocytosis in blood donors in Turkey
Yagci M., YEGİN Z. A., Yenicesu I., Suyani E., Ulu B. U., Inci K., et al.
HEMATOLOGY
, vol.23, no.1, pp.25-29, 2018 (SCI-Expanded, Scopus)
2018
201861. İmmünsüpresif Hastalarda Epstein-Barr Virüs (EBV) Viral Yükü ile Klinik Tablo Arasındaki ilişki
ÇOLAK M., ALTAY KOÇAK A., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
Istanbul Medical Journal , vol.19, pp.7-13, 2018 (Peer-Reviewed Journal)
2018
201862. İmmunsupresif hastalarda EBV viral yükü ile klinik tablo arasında ilişki
altay koçak a., çolak m., dalgıç b., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
İstanbul Medical Journal , vol.19, pp.7-13, 2018 (Peer-Reviewed Journal)
2018
201863. Capecitabine Induced Therapy Related Acute Myeloblastic Leukemia with t(10;11) (q22;q23) in a Patient with Breast Cancer
ÖZKURT Z. N., Ocal R., Pepeler M. S., Ulkuden B.
GAZI MEDICAL JOURNAL
, vol.29, no.1, pp.57-58, 2018 (ESCI)
2018
201864. İmmünsüpresif Hastalarda Epstein-Barr Virüs (EBV) Viral Yükü ile Klinik Tablo Arasındaki ilişkiRelationship between Epstein-Barr Virus (EBV) İnfection and Viral Load in İmmunosuppressive Patients
ÇOLAK M., koçak a., DALGIÇ B., ÖZKURT Z. N., FİDAN I., ÖZKAN S., et al.
İstanbul Med J , 2018 (Peer-Reviewed Journal)
2017
201765. Factors affecting hematopoietic stem cell mobilization and apheresis in allogeneic donors: The role of iron status
ÖZKURT Z. N., Batmaz L., YEGİN Z. A., İLHAN Ç.
TRANSFUSION AND APHERESIS SCIENCE
, vol.56, no.3, pp.470-473, 2017 (SCI-Expanded)
2017
201766. Assessment of soluble entothelial protein c receptor and thrombomodulin levels in newly diagnosed myeloprolipherative neoplasms
çalkaya s., YEGİN Z. A., GÜLBAHAR Ö., ma ç., ÖZKURT Z. N., ACAR K., et al.
World Clin J Med Sci , vol.1, no.2, pp.84-88, 2017 (Peer-Reviewed Journal)
2017
201767. Şiddetli eritrodermi ve dermatopatik lenfadenopati ile ortaya çıkan akut myeloid lösemi olgusu
öcal r., pepeler s., toker g., ÖZKURT Z. N.
LLM Dergi , vol.1, no.1, pp.18-21, 2017 (Peer-Reviewed Journal)
2017
201768. Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
ÖZKURT Z. N., Sucak G. T., Aki S. Z., Yagci M., Haznedar R.
CANCER INVESTIGATION
, vol.35, no.3, pp.195-201, 2017 (SCI-Expanded)
2017
201769. Ferritin is a predictor of prognosis in myelodysplastic syndrome?
YEGİN Z. A., HIZAL M., EREN SADİOĞLU R., ÖZKURT Z. N., Sucak G. T.
World Clin J Med Sci , vol.1, no.2, pp.89-95, 2017 (Peer-Reviewed Journal)
2017
201770. Acute Myeloid Leukemia Presented with Severe Erythrodermia and Dermatopathic Lymphadenitis
ÖCAL R., ÖZKURT Z. N., pepeler m. s., toker g., YAĞCI A. M.
Lösemi Lenfoma Miyelom Araştırmaları Dergisi , vol.1, no.1, pp.18-21, 2017 (Peer-Reviewed Journal)
2016
201671. A Rare and Mortal infection agent in patients with hematological malignancies: Saprochaete capitata Hematolojik Maligniteli Hastalarda Nadir ve Mortal Bir Enfeksiyon Etkeni: Saprochaete capitata
Aydin Kaynar L., ÖZKURT Z. N., Ulkuden B., GÜZEL TUNÇCAN Ö., Aygencel G., AKYÜREK N., et al.
Mikrobiyoloji Bulteni
, vol.50, no.4, pp.613-620, 2016 (SCI-Expanded)
2016
201672. Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels?
KÖKTÜRK N., Yildirim F., AYDOĞDU M., Aki S. Z., YEGİN Z. A., ÖZKURT Z. N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.1, pp.34-40, 2016 (SCI-Expanded)
2016
201673. A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
ÖZKURT Z. N., Suyani E., Haznedar R., Yagci M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.3, pp.231-235, 2016 (SCI-Expanded)
2015
201574. Acute myocardial infarction as a finding of acute promyelocytic leukemia-related coagulation disorder
ÖZKURT Z. N., Aypar E., Sarifakiogullari S., TAÇOY G., Ozdag M., Kahraman S., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, vol.26, no.8, pp.949-952, 2015 (SCI-Expanded)
2015
201575. Investigation of BK and JC virus DNA positivities by real-time polymerase chain reaction in immunosuppressive patients
Colak M., Altay A., ERTEN Y., ÖZKURT Z. N., Pynar A., Bozdayy G.
JOURNAL OF CLINICAL VIROLOGY
, vol.70, 2015 (SCI-Expanded)
2015
201576. Detection of EBV infection by real-time PCR method in immunosuppressive patients
Altay A., Colak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
JOURNAL OF CLINICAL VIROLOGY
, vol.70, 2015 (SCI-Expanded)
2015
201577. Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
Demirci T., YEGİN Z. A., Kursunoglu N., Yilmaz Z., Suyant E., ÖZKURT Z. N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.32, no.1, pp.29-34, 2015 (SCI-Expanded)
2015
201578. Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report
TAÇOY G., Cengel A., ÖZKURT Z. N., TÜRKOĞLU S.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
, vol.43, no.1, pp.78-81, 2015 (ESCI)
2014
201479. Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors
Acar K., Aki S. Z., ÖZKURT Z. N., BOZDAYI G., Rota S., Sucak G. T.
TURKISH JOURNAL OF HEMATOLOGY
, vol.31, no.3, pp.276-285, 2014 (SCI-Expanded)
2014
201480. Relationship Between Teicoplanin Use and Increase in Minimal Inhibitor Concentrations of Coagulase-Negative Staphylococci
Güzel Tunçcan Ö., Dizbay M., Tozlu Keten D., Özkurt Z. N., Sucak G., Şenol E.
Gazi Medical Journal , vol.25, pp.97-99, 2014 (Scopus)
2014
201481. A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis
Degertekin C. K., ÖZKURT Z. N., AKYÜREK N., Yagci M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.30, 2014 (SCI-Expanded)
2013
201382. TCTP/HRF pathway and angiogenesis: A feasible intercourse in chronic lymphocytic leukemia
Yagci M., YEGİN Z. A., AKYÜREK N., KAYHAN H., ÖZKURT Z. N., Sucak G. T., et al.
LEUKEMIA RESEARCH
, vol.37, no.6, pp.665-670, 2013 (SCI-Expanded)
2012
201283. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation
Sucak G. T., Yasar D. G., YEGİN Z. A., ERGÜN M. A., ÖZKURT Z. N., Aki S. Z., et al.
ANNALS OF HEMATOLOGY
, vol.91, no.8, pp.1281-1287, 2012 (SCI-Expanded)
2012
201284. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?
Aydogdu M., Ozyilmaz E., Kokturk N., YEGİN Z. A., ÖZKURT Z. N., Aki Z. S., et al.
MINERVA MEDICA
, no.3, pp.189-198, 2012 (SCI-Expanded)
2011
201185. Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival
Sucak G. T., ÖZKURT Z. N., Suyani E., Yasar D. G., Akdemir O. U., Aki Z., et al.
ANNALS OF HEMATOLOGY
, vol.90, no.11, pp.1329-1336, 2011 (SCI-Expanded)
2011
201186. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities
Aki S. Z., PAŞAOĞLU H., YEGİN Z. A., Suyani E., Demirtas C., ÖZKURT Z. N., et al.
HEMATOLOGY
, vol.16, no.5, pp.284-290, 2011 (SCI-Expanded)
2011
201187. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation
Yegin Z. A., Pasaoglu H., Aki S. Z., Ozkurt Z. N., Demirtas C., Yagci M., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
, vol.33, no.4, pp.414-423, 2011 (SCI-Expanded)
2011
201188. Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT
Suyani E., Sucak G. T., Aki S. Z., YEGİN Z. A., ÖZKURT Z. N., Yagci M.
ANNALS OF HEMATOLOGY
, vol.90, no.6, pp.685-691, 2011 (SCI-Expanded)
2011
201189. Value of F-18-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma
Haznedar R., Aki S. Z., Akdemir O. U., ÖZKURT Z. N., Ceneli O., Yagci M., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.38, no.6, pp.1046-1053, 2011 (SCI-Expanded)
2010
201090. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?
Sucak G., Suyani E., Ozkurt Z. N., Yegin Z. A., Aki Z., Yagci M.
HEMATOLOGICAL ONCOLOGY
, vol.28, no.4, pp.180-184, 2010 (SCI-Expanded)
2010
201091. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload
Ozyilmaz E., Aydogdu M., Sucak G., Aki S. Z., Ozkurt Z. N., Yegin Z. A., et al.
BONE MARROW TRANSPLANTATION
, no.10, pp.1528-1533, 2010 (SCI-Expanded)
2010
201092. The Impact of Bone Marrow Fibrosis on the Outcome of Hematopoietic Stem Cell Transplantation
Suyani E., Aki S. Z., Yegin Z. A., Ozkurt Z. N., Altindal S., Akyurek N., et al.
TRANSPLANTATION PROCEEDINGS
, vol.42, no.7, pp.2713-2719, 2010 (SCI-Expanded)
2010
201093. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates
GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., ERBAŞ G., Aki S. Z., ŞENOL E., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, vol.14, 2010 (SCI-Expanded)
2010
201094. Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies
Yagci M., ÖZKURT Z. N., YEGİN Z. A., Aki Z., Sucak G. T., Haznedar R.
HEMATOLOGY
, vol.15, no.4, pp.240-244, 2010 (SCI-Expanded)
2010
201095. Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
YEGİN Z. A., ÖZKURT Z. N., Aki S. Z., Sucak G. T.
TRANSFUSION AND APHERESIS SCIENCE
, vol.42, no.3, pp.239-245, 2010 (SCI-Expanded)
2010
201096. Iron Overload: Predictor of Adverse Outcome in Hematopoietic Stem Cell Transplantation
Sucak G. T., Yegin Z. A., Ozkurt Z. N., Aki S. Z., Yagci M.
TRANSPLANTATION PROCEEDINGS
, vol.42, no.5, pp.1841-1848, 2010 (SCI-Expanded)
2010
201097. Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia
YEGİN Z. A., Ozkurt Z. N., Yaci M.
EUROPEAN JOURNAL OF HAEMATOLOGY
, vol.84, no.5, pp.406-411, 2010 (SCI-Expanded)
2010
201098. Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients
Ceneli O., ÖZKURT Z. N., Acar K., Rota S., Aki S. Z., YEGİN Z. A., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, vol.16, no.14, pp.1765-1771, 2010 (SCI-Expanded)
2010
201099. Thrombopoietic cytokines and platelet count in multiple myeloma
ÖZKURT Z. N., Yagci M., Sucak G. T., Kirazli S., Haznedar R.
PLATELETS
, vol.21, no.1, pp.33-36, 2010 (SCI-Expanded)
2010
2010100. Factors Affecting Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplantation
ÖZKURT Z. N., YEGİN Z. A., Suyani E., Aki S. Z., Acar K., Yagci M., et al.
JOURNAL OF CLINICAL APHERESIS
, vol.25, no.5, pp.280-286, 2010 (SCI-Expanded)
2009
2009101. Impact of ABO-Incompatible Donor on Early and Late Outcome of Hematopoietic Stem Cell Transplantation
Ozkurt Z. N., Yegin Z. A., Yenicesu I., Aki S. Z., Yagci M., Sucak G. T.
TRANSPLANTATION PROCEEDINGS
, vol.41, no.9, pp.3851-3858, 2009 (SCI-Expanded)
2009
2009102. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma
ÖZKURT Z. N., Sucak G. T., Aki S. Z., Yagci M., Erdem O.
CUTANEOUS AND OCULAR TOXICOLOGY
, vol.28, no.3, pp.141-143, 2009 (SCI-Expanded)
2009
2009103. Diagnostic Usefulness Of Quantitative 18F-FDG PET/CT Data In The Detection Of Bone Marrow Involvement In Primary Staging Of Lymphoma Patients
Cakir T., Gokcora N., Akdemir Ü. Ö., Karabacak N., Akyurek N., Cakir A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, vol.36, pp.241, 2009 (SCI-Expanded)
2009
2009104. Thrombopoietic Cytokine and P-Selectin Levels in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Decrease in Posttransplantation P-Selectin Levels Might Predict the Degree of Maximum Response
Aki S. Z., Sucak G. T., PAŞAOĞLU H., ÖZKURT Z. N., YEGİN Z. A., Ofluoglu E., et al.
CLINICAL LYMPHOMA & MYELOMA
, vol.9, no.3, pp.229-233, 2009 (SCI-Expanded)
2009
2009105. Melanocortin-4 Receptor Gene Polymorphisms in Obese Patients
Yurtcu E., Yilmaz A., Ozkurt Z. N., Kolukisa E., Yilmaz M., KELEŞ H., et al.
BIOCHEMICAL GENETICS
, vol.47, pp.295-300, 2009 (SCI-Expanded)
2009
2009106. Allogeneic stem cell transplantation for severe aplastic anemia: Graft rejection remains a problem
Aki S. Z., Sucak G. T., ÖZKURT Z. N., YEGİN Z. A., Yagci M., Haznedar R.
TRANSFUSION AND APHERESIS SCIENCE
, vol.40, no.1, pp.5-11, 2009 (SCI-Expanded)
2009
2009107. Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment
Konca C., Oezkurt Z. N., Deger M., Aki Z., Yagci M.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, vol.89, no.1, pp.58-62, 2009 (SCI-Expanded)
2009
2009108. The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women
Ozkurt B., ÖZKURT Z. N., Altay M., Aktekin C. N., ÇAĞLAYAN O., Tabak Y.
EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY
, vol.20, no.2, pp.78-84, 2009 (SCI-Expanded)
2008
2008109. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak G. T., Yegin Z. A., Oezkurt Z. N., Aki S. Z., Karakan T., Akyol G.
BONE MARROW TRANSPLANTATION
, vol.42, no.7, pp.461-467, 2008 (SCI-Expanded)
2008
2008110. Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: Risk factors for posttransplantation cardiac toxicity
Sucak G. T., Ozkurt Z. N., Aki Z., Yagci M., Cengel A., Haznedar R.
TRANSPLANTATION PROCEEDINGS
, vol.40, no.5, pp.1586-1590, 2008 (SCI-Expanded)
2008
2008111. Impact of adiponectin on left ventricular mass index in non-complicated obese subjects
Ebinc H., Ebninc F. A., ÖZKURT Z. N., DOĞRU M. T., Tulmac M., Yilmaz M., et al.
ENDOCRINE JOURNAL
, vol.55, no.3, pp.523-528, 2008 (SCI-Expanded)
2008
2008112. Adiponectin and insulin resistance in obesity-related diseases
Ebinc H., Ozkurt Z. N., Ebin F. A., Yilmaz M., Caglayan O.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, vol.36, no.1, pp.71-79, 2008 (SCI-Expanded)
2008
2008113. Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women
Ebinc H., Ozkurt Z. N., Ebin F. A., Ucardag D., Caglayan O., Yilmaz M.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, vol.36, no.1, pp.80-87, 2008 (SCI-Expanded)
2007
2007114. Treatment of sinusoidal obstruction syndrome with defibrotide: A single-center experience
Sucak G. T., Aki Z. S., Yagci M., Yegin Z. A., Ozkurt Z. N., Haznedar R.
TRANSPLANTATION PROCEEDINGS
, vol.39, no.5, pp.1558-1563, 2007 (SCI-Expanded)
2007
2007115. Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure
Ebinc H., Ebinc F. A., Ozkurt Z. N.
SAUDI MEDICAL JOURNAL
, vol.28, no.3, pp.472-473, 2007 (SCI-Expanded)
2007
2007116. Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population
Guliter S., Yakaryilmaz F., Ozkurt Z. N., Ersoy R., Ucardag D., Caglayan O., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, vol.13, no.10, pp.1599-1601, 2007 (SCI-Expanded)
2007
2007117. Frequency of microalbuminuria and its relationship with other atherosclerotic risk factors in nondiabetic hypertensive patients
ÖZKURT Z. N., fatma e., KELEŞ H., EBİNÇ H., GÜLİTER S.
Anadolu Kardiyoloji Dergisi
, 2007 (Peer-Reviewed Journal)
2006
2006118. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases
Sezikli M., Guliter S., Apan T. Z., Aksoy A., Keles H., Ozkurt Z. N.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
, vol.60, no.10, pp.1239-1243, 2006 (SCI-Expanded)
2006
2006119. Relationship of left ventricular mass to insulin sensitivity and body mass index in healthy individuals
Ebinc H., Ayerden Ebinc F., Nur Ozkurt Z. N., Dogru T., Yilmaz M.
ACTA CARDIOLOGICA
, vol.61, no.4, pp.398-405, 2006 (SCI-Expanded)
2005
2005120. Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis
Ozkurt Z. N., Guliter S., Keles I., Keles H.
CLINICAL RHEUMATOLOGY
, vol.24, no.6, pp.665-666, 2005 (SCI-Expanded)
2005
2005121. The relationship between atherosclerotic risk factors and carotid atherosclerosis in hemodialysis and peritoneal dialysis patients
Ozkurt Z. N., Bali M., Guz G., Ozdemir H., Cevik C., Sindel S.
DIALYSIS & TRANSPLANTATION
, vol.34, no.12, pp.854-859, 2005 (SCI-Expanded)
2005
2005122. Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease
Altok K., Guz G., Ozdemir H., Erten Y., Atalay V., Bicik Z., et al.
INTERNATIONAL HEART JOURNAL
, vol.46, no.2, pp.255-264, 2005 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2024
20241. PRİMER MİYELOFİBROZİS’TE ALLOJENEİK KÖK HÜCRE NAKLİ : TEK MERKEZ DENEYİMİ
YEGİN Z. A., ÖZKURT Z. N., SAVAŞ E. M., YILDIZ Ş., KÖK M. İ., YAĞCI A. M.
50. ULUSAL HEMATOLOJİ KONGRESİ, 29 October 2024, (Full Text)
2024
20242. RELAPS REFRAKTER AKUT LÖSEMİ KURTARMA TEDAVİSİNDE FLAMSA PROTOKOLÜ FLAG-IDA'YA BİR ALTERNATİF OLABİLİR Mİ?
Savaş E. M., Bozkurt H. H., Kemer N. I., Yıldız Ş., Kök M. İ., Yegin Z. A., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, (Full Text)
2024
20243. YURT İÇİ VE YURT DIŞI AKRABA DIŞI DONÖRLERLE YAPILAN ALLOJENEİK KÖK HÜCRE NAKLİ SONUÇLARININ KARŞILAŞTIRILMASI
YILDIZ Ş., SAVAŞ E. M., İLHAN Ç., YEGİN Z. A., ÖZKURT Z. N.
50. ULUSAL HEMATOLOJİ KONGRESİ, 29 October 2024, (Full Text)
2024
20244. Lösemide Kısa Ardışık Tekrar Dizileri (Str) Belirteçlerinin Değerlendirilmesi
Gökçen S., Kayhan H., Özkurt Z. N., Yegin Z. A., Yağcı A. M.
9. Ulusal Transplantasyon İmmünolojisi ve Genetiği Kongresi, Antalya, Turkey, 18 - 21 April 2024, pp.7, (Summary Text)
2024
20245. DONÖR HEMATOLOJİK PARAMETRELERİNİN ERKEN DÖNEM DONÖR KOMPLİKASYONLARINA ETKİSİ (DART PROJESİ)
AYDIN M. S., YILDIZ Ş., YEGİN Z. A., ÖZKURT Z. N., YAVAŞOĞLU F., İLHAN Ç., et al.
16. ULUSAL KEMİK İLİĞİ TRANSPLANTASYONU VE HÜCRESEL TEDAVİLER KONGRESİ, 07 March 2024, (Full Text)
2024
20246. ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI 100.GÜN PLATELET DEĞERİ SAĞKALIM VE RELAPS İÇİN ÖNGÖRÜCÜ BİR BELİRTEÇ OLABİLİR Mİ?
YILDIZ Ş., SAVAŞ E. M., ŞEKER A., ÖZKURT Z. N., UYAR GÖÇÜN F. P., AKYÜREK N., et al.
16. ULUSAL KEMİK İLİĞİ TRANSPLANTASYONU VE HÜCRESEL TEDAVİLER KONGRESİ, 07 March 2024, (Full Text)
2023
20237. ECP VERSUS RUXOLITINIB IN STEROID-REFRACTORY ACUTE GVHD - A RETROSPECTIVE STUDY BY THE EBMT TRANSPLANT COMPLICATIONS WORKING PARTY
Penack O., Peczynski C., Boreland W., Lemaitre J., Afanasyeva K., Kornblit B., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.290-291, (Summary Text)
2023
20238. EVALUATION OF COVID-19 VACCINE ANTIBODY RESPONSES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: USING RUXOLUTINIB OR IBRUTINIB NEGATIVELY EFFECTS VACCINE ANTIBODY RESPONSES
SAVAŞ E. M., YILDIZ Ş., ÖZKURT Z. N., BALTACI Z., GÜZEL TUNÇCAN Ö., YEGİN Z. A., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.399-400, (Summary Text)
2023
20239. DOES THE CONSOLIDATION TREATMENT EFFICIENT AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA PATIENTS? WHICH REGIMEN IS FEASIBLE?
ÖZKURT Z. N., YILDIZ Ş., DEMİREZEN A., YEGİN Z. A., YAĞCI A. M.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.484-485, (Summary Text)
2023
202310. EVALUATION OF COVID-19 VACCINE ANTIBODY RESPONSES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: USING RUXOLUTINIB OR IBRUTINIB NEGATIVELY EFFECTS VACCINE ANTIBODY RESPONSES P 364
SAVAŞ E. M., YILDIZ Ş., ÖZKURT Z. N., BALTACI Z., GÜZEL TUNÇCAN Ö., YEGİN Z. A., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Paris, France, 23 - 26 April 2023, vol.58, pp.299-300, (Summary Text)
2023
202311. PROGNOSTIC IMPACT OF LOW SERUM MAGNESIUM LEVELS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Savaş E. M., Yegin Z. A., Kök M. İ., Karayel H. T., Özkurt Z. N., Bozer M. N., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.364, (Summary Text)
2023
202312. A Treatment Option in the Acute GVHD: Mesenchymal Stem Cell Therapy
Çalışkan E., Soyugür A., Özkurt Z. N., Yegin Z. A., Adışen E.
8th International Dermatology & Cosmetology Congress- INDERCOS, İstanbul, Turkey, 9 - 12 March 2023, pp.121-122, (Full Text)
2022
202213. İnvaziv Pulmoner Aspergilloz Şüpheli Hastalarda Galaktomannan ve Beta Glukan Antijen Testlerinin Karşilaştir
ÇUHADAR T., KALKANCI A., GÜZEL TUNÇCAN Ö., YEGİN Z. A., ÖZKURT Z. N., KÖKTÜRK N., et al.
XL. ULUSLARARASI TÜRK MIKROBIYOLOJI KONGRESI, Turkey, 16 November 2022, (Full Text)
2022
202214. The impact of thrombopoietin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplant recipients
BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., UYAR GÖÇÜN F. P., et al.
The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation, 19 - 23 March 2022, vol.57, pp.362-363, (Summary Text)
2022
202215. Thiotepa-based reduced intensity conditioning are a valid alternative to total-body irradiation-based regimens in patients with acute lymphoblastic leukemia: A study of the alwp of the ebmt
Battıpaglıa G., L M., L S., R A., Özkurt Z. N., B J., et al.
the 48th Annual meeting of tha European Blood and Marrow Transplantation, Praha, Czech Republic, 19 - 23 March 2022, vol.57, no.100416, pp.163-164, (Summary Text)
2022
202216. The impact of thrombopoirtin receptor agonists on bone marrow fibrosis in allogeneic stem cell transplantaion recipients
Bostankolu Değirmenci B., Yegin Z. A., Dikyar A., Aydın Kaynar L., Özkurt Z. N., Uyar Göçün F. P., et al.
The 48 th Annual Meeting of the European Blood and Marrow, Praha, Czech Republic, 19 - 23 March 2022, vol.57, no.100416, pp.362-363, (Summary Text)
2021
202117. MULTİPL MYELOMLU HASTADA OKHN KARARINDA KAPSAMLI GERİATRİK TESTLERİN ROLÜ VE ZAMANLAMASI NE OLMALIDIR? PROSPEKTİF ANALİZ
DURMUŞ DEMİREL K., ÖZKURT Z. N., TUNA DOĞRUL R., AYDIN KAYNAR L., YEGİN Z. A., GÖKER B., et al.
47.Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021, pp.216-217, (Full Text)
2021
202118. THE PROCESS OF SARS-COV-2 PCR POSITIVITY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Altay Koçak A., Güzel Tunçcan Ö., Büyükkoruk M., Dikyar A. A., Sarzhanova S., Özkurt Z. N., et al.
ESCV, 15 - 17 September 2021, pp.126, (Full Text)
2021
202119. SeçilmişTirotoksikoz Olgularında Plazmaferez Tedavisi- Tek Merkez Deneyimi
Kahraman S. S., Yıldız B., Yalçın M. M., Sel A. T., Dikyar A., Eroğlu Altınova A., et al.
42. Endokrinoloji ve Metabolizma Hastalıkları Kongresi, 19 - 23 May 2021, pp.633, (Summary Text)
2020
202020. The determinative role of patient-controlled-analgesia (PCA) in the early course of allogeneic hematopoietic stem cell transplantation
haşimoğlu k., can f., TERTEMİZ O. F., DİKYAR A., AKÇALI D. T., ÖZKURT Z. N., et al.
46th Annual meeting of European Society for Blood Marrow Transplantation: Physician Poster Session, United Kingdom, 29 August - 01 September 2020, vol.55, pp.181-714, (Summary Text)
2020
202021. Gebelik ve Covid 19 ile tetiklenen TTP : Olgu Sunumu
AYDIN KAYNAR L., DİKYAR A., YEGİN Z. A., ÖZKURT Z. N., YAĞCI A. M.
Hematoloji Uzmanlık Derneği Ulusal Kongresi, Turkey, 12 - 15 December 2020, (Full Text)
2020
202022. Comparison of pre-transplant Comorbidity Indices in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YAĞCI A. M.
The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 29 August - 01 September 2020, vol.55, pp.190-191, (Summary Text)
2020
202023. Covid-19 enfeksiyonunun hematolojik maligniteli hastalar üzerine etkileri
AYDIN KAYNAR L., GÜZEL TUNÇCAN Ö., DİKYAR A., BOSTANKOLU DEĞİRMENCİ B., YEGİN Z. A., ÖZKURT Z. N., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Full Text)
2020
202024. Allojeneı̇k Kök Hücre Naklı̇ Yapılan Hastalarda Trombopoetı̇n Reseptör Agonı̇stı̇ Tedavı̇sı̇ Ve Kemı̇k İlı̇ğİ Fı̇brozı̇sı̇ İlişkisi
BOSTANKOLU DEĞİRMENCİ B., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, pp.119, (Full Text)
2020
202025. Can Bone Marrow Cells Be Differentiated and Counted Using a Novel Hematology Analyzer?
KAYA Z., ÖZKURT Z. N., YAĞCI A. M., KOÇAK Ü.
ISTH 2020, Venedik, Italy, 12 July 2020, (Full Text)
2020
202026. ALLOJENEİK NAKİLDE PROFİLAKTİK G-CSF KULLANIMININ ERKEN KOMPLİKASYONLAR, AKUT VE KRONİK GVHH’NA ETKİSİ VAR MIDIR?
ÖZKURT Z. N., AYDIN KAYNAR L., DİKYAR A., CAN F., YEGİN Z. A., GÖRAL Ş., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 5 - 07 March 2020, (Summary Text)
2020
202027. MULTİPL MYELOMDA DONDURULMAMIŞ ÜRÜN İLE EŞ ZAMANLI OTOLOG KÖK HÜCRE NAKLİ İLE STANDART UYGULAMANIN KARŞILAŞTIRILMASI
ÖZKURT Z. N., DİKYAR A., YEGİN Z. A., AYDIN KAYNAR L., ATEŞ E., KARACAOĞLU YURDAGÜL Ö.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Turkey, 05 March 2020, pp.54, (Full Text)
2020
202028. OKHN UYGULANMIŞ YÜKSEK RİSKLİ HL’DE BRENTUKSİMABVEDOTİN KONSOLİDASYONU GERÇEK YAŞAM VERİLERİ:ÇOK MERKEZLİ ÇALIŞMA
AKAY O. M., ÖZBALAK M. M., YILDIZ B., PEHLİVAN M., YİĞENOĞLU T., UZAY A., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.46, (Summary Text)
2020
202029. Erişkin hemofili hastalarımızın analizi:Tek merkez deneyimi
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., DİKYAR A., YAĞCI A. M.
Hemofili vakalarla eğitim sempozyumu, Turkey, 21 - 23 February 2020, (Full Text)
2020
202030. TOTAL VÜCUT IŞINLAMALI HAZIRLIK REJİMİ VERİLEN ERİŞKİN KÖK HÜCRE NAKLİ HASTALARINDA DEFİBROTİD PROFİLAKSİSİ ETKİN MİDİR?
DİKYAR A., ÖZKURT Z. N., YEGİN Z. A., AYDIN KAYNAR L., İLHAN Ç.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Turkey, 5 - 07 March 2020, pp.60, (Full Text)
2019
201931. “Evaluation of Colistin-induced nephrotoxicity in critically-ill haematology patients”
AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., CAN F., AYDIN KAYNAR L., ÖZKURT Z. N., YEĞİN Z. A., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, ANTALYA, 13 - 16 November 2019, vol.10, pp.47-48, (Full Text)
2019
201932. “Infections in Hematopoietic Stem Cell Transplantation Patients Admitted to Hematology Intensive Care Unit in Gazi University Hospital”
BARLAS T., AYGENCEL BIKMAZ Ş. G., TÜRKOĞLU M., CAN F., AYDIN KAYNAR L., ÖZKURT Z. N., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, ANTALYA, 13 - 16 November 2019, vol.10, pp.66-67, (Full Text)
2019
201933. Infections in Hematopoietic StemCel Transplantation Patients Admitted to Hematology Intensive Care Unit in Gazi University Hospital
Barlas T., Aygencel Bıkmaz Ş. G., Türkoğlu M., Can F., Aydın Kaynar L., Özkurt Z. N., et al.
16. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 8. Avrasya Yoğun Bakım Toplantısı, Antalya, Turkey, 13 - 16 November 2019, vol.10, pp.66-67, (Full Text)
2019
201934. Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients – the Diadem Study from the Chronic Malignancies Working Party of the EBMT
Anna W., Wang J., Wreede L., Sirait T., ÖZKURT Z. N., Snowden J., et al.
61th ASH Annual Meeting, 7 - 10 December 2019, (Summary Text)
2019
201935. OTOLOG KÖK HÜCRE NAKLİ ÖNCESİ KAPSAMLI GERİATRİK DEĞERLENDİRME YOL GÖSTERİCİ MİDİR?
KESTANE M., CAN F., DENİZ O., DİKYAR A., GÖKER B., YEGİN Z. A., et al.
45. Ulusal Hematoloji Kongresi, 30 October - 02 November 2019, (Summary Text)
2019
201936. Prognostic impact of pre-transplant TIM3 levels on transplant outcome in acute leukemia patients
YEGİN Z. A., Can F., Kaynar L. A., GÖKÇEN S., Sadioglu R. E., ÖZKURT Z. N., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.161-162, (Summary Text)
2019
201937. Impact of vitamin D levels on peripheral stem cell mobilization in autologous hematopoietic stem cell transplant recipients
Can F., YEGİN Z. A., ÖZKURT Z. N., Akdogan O., Kaynar L. A.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.591-592, (Summary Text)
2019
201938. THE IMPACT OF PRE-TRANSPLANT CELL-FREE DNA LEVELS ON LEUKEMIA RELAPSE AND TRANSPLANT RELATED COMLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
YEGİN Z. A., CAN F., GÖKÇEN S., SADİOĞLU R. E., ÖZKURT Z. N., İLHAN Ç., et al.
24th European Hematology Association (EHA) Congress, Amsterdam, Netherlands, 13 - 16 June 2019, (Summary Text)
2019
201939. The impact of Pre-Transplant Cell-Free DNA levels on leukemia relapse and transplant related complications in allogeneic hematopoetic stem cell transplant recipients
YEGİN Z. A., CAN F., GÖKÇEN S., EREN SADİOĞLU R., ÖZKURT Z. N., İLHAN Ç., et al.
24th Congress of the European Hematology Association, Amsterdam, Netherlands, 13 - 16 June 2019, (Summary Text)
2019
201940. Hyperlactatemia, lactate clearance and outcome in critically ill patients with hematological malignancies
İNCİ K., GÖKÇE O., TÜRKOĞLU M., YAĞCI A. M., ÖZKURT Z. N., AYDIN KAYNAR L., et al.
22nd International Intensive Care Symposium, İstanbul, Turkey, 3 - 04 May 2019, (Summary Text)
2019
201941. COMPARISON OF CONSOLIDATION STRATEGIES IN ACUTE MYELOID LEUKEMIA: STANDARD CHEMOTHERAPYVS AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Dikyar A. A., Yeğin Z. A., CAN F., Kaynar L. A., ÖZKURT Z. N., YAĞCI A. M.
7th International Congress on Leukemia Lymphoma Myeloma - 2019, İstanbul, Turkey, 3 - 05 May 2019, vol.1, pp.38-39, (Full Text)
2019
201942. Comparison of consolidation strategies in acute myeloid leukemia: Standard chemotherapy vs autologous hematopoietic stem cell transplantation
DİKYAR A., YEGİN Z. A., AYDIN KAYNAR L., CAN F., ÖZKURT Z. N., YAĞCI A. M.
7Th International Congress Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, vol.36, pp.38-39, (Full Text)
2019
201943. EFFICACY OF HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUSHEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTSWITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
CAN F., YEGİN Z. A., DİKYAR A., AYDIN KAYNAR L., ÖZKURT Z. N., YAĞCI A. M.
7th International Congress Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Full Text)
2019
201944. MESENCHYMAL STEM CELL INFUSION IN GRAFT VERSUS HOST DISEASE:A SINGLE CENTER EXPERIENCE
AYDIN KAYNAR L., YÜCESU E., CAN F., DİKYAR A., İLHAN Ç., ÖZKURT Z. N., et al.
7th International Congress Leukemia Lymphoma Myeloma, 02 May 2019 - 04 May 2009, (Full Text)
2019
201945. hyperlactatemia,lactate clearance and outcome in critically ill patients with hematological malignencies
İNCİ K., GÖKÇE O., TÜRKOĞLU M., YAĞCI A. M., ÖZKURT Z. N., AYDIN KAYNAR L., et al.
22nd ınternational intensive care symposium, 1 - 02 May 2019, (Full Text)
2019
201946. Second autologous hematopoietic stem cell transplant versus chemoimmunıtherapy in relapsed multiple myeloma after first transplantation : Single center data
CAN F., öcal r., AYDIN KAYNAR L., YEGİN Z. A., YAĞCI A. M., haznedar r., et al.
The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation, Frankfurt, Germany, 23 - 27 March 2019, vol.54, pp.502-503, (Summary Text)
2017
201747. Management and outcome of patients with diffuse large B-Cell lymphoma relapsed after autologous hematopoietic stem cell transplantation (auto-HSCT): A retrospective analysis of the lymphoma working party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
gonzalez e., boumendil a., blaise d., trneny m., masszi t., finel h., et al.
59th Annual Meeting Exposition, 9 - 12 December 2017, (Summary Text)
2018
201848. Spinoserebellar Ataksili Hastada Miyelofibrozis Nedeniyle Yapılan Allojeneik Kök Hücre Nakli Sonrası Nörolojik İyileşme
Baltacı Z., Aydın Kaynar L., Yegin Z. A., Özkurt Z. N.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.368-369, (Summary Text)
2018
201849. SPİNOSEREBELLAR ATAKSİLİ HASTADA MİYELOFİBROZİS NEDENİYLE YAPILAN ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI NÖROLOJİK İYİLEŞME
CAN F., AYDIN KAYNAR L., BALTACI Z., SARIER A., AKYÜREK A., YEGİN Z. A., et al.
44.Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October 2018, pp.368-369, (Full Text)
2108
210850. ERİŞKİNDE ALL İDAME TEDAVİ YAN ETKİLERİ, YAN ETKİ YÖNETİMİ VE YAN ETKİLERİN SAĞ KALIM İLE İLİŞKİSİ
MERVE ECEM E. Y., ÖCAL R., GÖKÇEN S., YEĞİN Z. A., YAĞCI A. M., ÖZKURT Z. N.
44. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October 2108 - 03 November 2018, (Summary Text)
2018
201851. T HÜCRELİ BÜYÜK GRANÜLER LENFOSİTİK LÖSEMİ VE KRONİK MYEOİD LÖSEMİ BİRLİKTELİĞİ, OLGU SUNUMU
CAN F., AYDIN KAYNAR L., DİKYAR A., YAĞCI A. M., ÖZKURT Z. N., YEGİN Z. A.
44.Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.233, (Full Text)
2018
201852. Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study
Greenfield D. M., Salooja N., Peczynski C., van der Werf S., Schoemans H., Hill K., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)
2018
201853. Is the End Close for the Graft-Versus-Host Disease That Is a Big Problem Following Allogeneic Hematopoetic Stem Cell Transplantation?
İLHAN O., Seval G. C., ÖZKURT Z. N., Ural A. U., Ayli M., Sevindik O. G., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)
2018
201854. Investigation of EBV infection in patients with acute lymphoblastic leukemia and lymphoma
ÇOLAK M., Sarzhanova S., ÖZKURT Z. N., YEGİN Z. A., FİDAN I., ÇAĞLAR K., et al.
21st Annual Meeting of European Society for Clinical Virology, ATİNA, Greece, 23 - 26 September 2018, (Summary Text)
2018
201855. Investigation of JCV positivity in patients with bone marrow transplant
ÇOLAK M., ALTAY KOÇAK A., Muftah H., ÖZKURT Z. N., Yeğin Z. A., BOZDAYI G.
21st Annual Meeting of European Society for Clinical Virology, Atina, Greece, 23 - 26 September 2018, (Summary Text)
2018
201856. Investigation of Epstein Barr Virus Infection in Patients with Acute Lymphoblastic Leukemia and Lymphoma
ÇOLAK M., SARZHANOVA S., ÖZKURT Z. N., FİDAN I., ÇAĞLAR K., BOZDAYI G.
21th Annual Meeting of the European Society for Clinical Virology Congress (ESCV), 23 - 26 September 2018, (Summary Text)
2018
201857. In vivo T-cell depletion in patients with myelofibrosis transplanted from an HLA matched sibling donor: an EBMT study
Robin M., Chevret S., Koster L., Wolschke C., Yakoubagha I., Bourhis J., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.49-51, (Summary Text)
2018
201858. Determinants of physical inactivity in hematopoietic stem cells recipients
Bargi G., Guclu M., Özkurt Z. N., Yagci M.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201859. Upper extremity aerobic exercise training improves exercise capacity in stem cell recipients
Bargi G., Guclu M., Özkurt Z. N., Yagci M.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201860. Exercise capacity, physical activity, quality of life in newly diagnosed hematologic malignancies
Çelik Z., Guclu M., Özkurt Z. N.
28th International Congress of the European-Respiratory-Society (ERS), Paris, France, 15 - 19 September 2018, vol.52, (Summary Text)
2018
201861. Exercise capacity, muscle strength and quality of life in physical active and inactive hematopoietic stem cells recipients
Barğı G., Boşnak Güçlü M., Özkurt Z. N., Yağcı A. M.
1st International Congress on Physiotechnotherapy, Sarajevo, Bosnia And Herzegovina, 9 - 13 May 2018, (Summary Text)
2018
201862. Exercise capasity, muscle strength and quality of life in physical active and inactive hematopoietic stem cell recipients
bağrı g., güçlü m. b., ÖZKURT Z. N., YAĞCI A. M.
international Congress on Physiotechnoyherapy, Bosnia And Herzegovina, 9 - 13 May 2018, pp.43, (Full Text)
2018
201863. Two antigens mismatch sibling donor against 9/10 B Antigen incompatible donor: Which one to choose?
CAN F., ÖZKURT Z. N., YEGİN Z. A.
6. Best of ASBMT/CIBMTR Tandem Meetings International Symposium, 13 - 15 April 2018, (Summary Text)
2018
201864. Hematopoetik Kök Hücre Nakli Alıcılarında Üst Ekstremite Aerobik Egzersiz Eğitiminin Kardiyopulmoner Sonuç Ölçümleri Üzerine Etkileri
Barğı G., Boşnak Güçlü M., Özkurt Z. N., Yağcı A. M.
Türk Toraks Derneği 21. Yıllık Kongresi, Antalya, Turkey, 11 - 15 April 2018, (Summary Text)
2017
201765. Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Gonzalez-Barca E., Boumendil A., Blaise D., Trneny M., Masszi T., Finel H., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
2017
201766. Myelodisplastik sendrom prognostik skorlama sistemleri ve diğer risk faktörlerinin geriye dönük test edilmesi
CAN F., PEPELER M. S., ÇAKMAK G., Ülküden B., ÖZKURT Z. N., YEGİN Z. A., et al.
43. Ulusal Hematoloji Kongresi, 1 - 04 November 2017, (Summary Text)
2017
201767. Allojeneik Kök Hücre Nakli Sonrası Masif Cilt Altı Amfizem Ve Pnömomediastinum Gelişen Bir Pulmoner Mukormikozis Olgusu
CAN F., BEDİR KESER G., YILDIZ G., YEGİN Z. A., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201768. İBRUTİNİBE YANIT ALINAN İKİ REFRAKTER B HÜCRELİ LENFOMA OLGUSU
AYDIN KAYNAR L., CAN F., ÇAKMAK G., ÖZKURT Z. N., YEGİN Z. A., YAĞCI A. M.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201769. Otolog Hematopoetık KöK Hücre Naklı̇nde Proflaktı̇k G-Csf Kullanımı Komplı̇kasyonları Azalttı Mı?
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., GÜZEL TUNÇCAN Ö., YAĞCI A. M., HAZNEDAR R.
43.Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.50-51, (Full Text)
2017
201770. CD30 + LENFOMALI OLGULARDA BRENTÜKSİMAB VEDOTİN TEDAVİSİ SONUÇLARININ DEĞERLENDİRİLMESİ: TEK MERKEZ DENEYİMİ
AYDIN KAYNAR L., ÖZKURT Z. N., YEGİN Z. A., YAĞCI A. M.
43.Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.53-54, (Full Text)
2017
201771. KRONİK MYELOSİTER LÖSEMİLİ HASTALARDA İMATİNİB TEDAVİSİNİN KESİLMESİ:ÇOK MERKEZLİ, İLERİYE DÖNÜK ÇALIŞMA 2.YIL SONUÇLARI
ÖZKURT Z. N., KARAKUŞ S., ÖCAL R., PEPELER M. S., GÖKÇEN S., YAĞCI A. M.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201772. Hematopoetik Kök Hücre Nakli Alıcılarında Fiziksel Aktivite Seviyesi, Egzersiz Kapasitesi Ve Yaşam Kalitesi
BARĞI G., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N., YAĞCI A. M.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201773. Kronik Lenfositik Lösemi Patofizyolojisinde Nükleolin: Bir Apopitoz Belirteci Olabilir mi?
YEGİN Z. A., Pepeler S., KAYHAN H., ÖZKURT Z. N., GÖKÇEN S., YAĞCI A. M.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201774. Esansiyel Trombositoz ve Primer Myelofibrozisli Hastalarda Kalretikülin Mutasyonu ve Kemik İliği Fibrozisi İlişkisi
ÇAKMAK G., KAYHAN H., GÖKÇEN S., ÖZKURT Z. N., YEGİN Z. A., HAZNEDAR R., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201775. Pulmonary functions, respiratory muscle strength and endurance in patients with newly diagnosed hematologic malignancy
ÇELİK Z., BOŞNAK GÜÇLÜ M., ÖZKURT Z. N.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201776. KRONİK KARACİĞER GREFT VERSUS HOST HASTALIĞINDA FİBROZİS DEĞERLENDİRMESİNDE ELASTOGRAFİNİN ROLÜ
PEPELER M. S., YEGİN Z. A., ÖZKURT Z. N., ÖZHAN OKTAR S., AKYOL G.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 04 October 2017, (Full Text)
2017
201777. Parvovirus B19 DNA Positivity in patients attended to a university hospital in Ankara, Turkey in 3 years process
ALTAY KOÇAK A., ÖZKURT Z. N., KARÇAALTINCABA D., BOZDAYI G.
20th Annual Meeting of the European Society for Clinical Virology, Stresa, Italy, 13 - 16 September 2017, (Summary Text)
2017
201778. Comparison of matched-unrelated donors versus alternative donor (9/10) unrelated donor, cord blob unit and haplo-identical donor) in allogeneic stem cell transplantation (allo-SCT) for acute lymphoblastic leukemia (ALL) in CR2: a report of 841 patients from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, France, 26 - 29 March 2017, vol.52, (Summary Text)
2017
201779. PROGNOSTIC SIGNIFICANCE OF SERUM BAFF, APRIL, TACI AND BCMA LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Mentese I. B., Yegin Z. A., Gokcen S., Ozkurt Z. N., Yagci M.
22nd Congress of the European-Hematology-Association, Madrid, Spain, 22 - 25 June 2017, vol.102, pp.720, (Summary Text)
2017
201780. Hematolojik maliniteli hastalarda solunum fonksiyonları, egzersiz kapasitesi, solunum kas kuvveti, aktivite dispnesi ve yorgunluğun sağlıklılarda karşılaştırılması
ÇELİK Z., BARĞI G., ÖZKURT Z. N., BOŞNAK GÜÇLÜ M.
Türk Toraks Derneği 20. Yıllık Kongresi, Antalya, Turkey, 5 - 09 April 2017, (Summary Text)
2017
201781. Erişkin yeni tanılanan akut lösemi hastalarında dispne, solunum fonksiyonları, depresyon ve yaşam kalitesi
BARĞI G., DÜNDAR Z. P., ÇELİK Z., ÖZKURT Z. N., BOŞNAK GÜÇLÜ M.
Türk Toraks Derneği 20. Yıllık Kongresi, Antalya, Turkey, 5 - 09 April 2017, (Summary Text)
2016
201682. Abstract 3497 An Alternative Donor Is a Valid Option Compared to a Matched Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2 A Report of 841 Patients from the EBMT Acute Leukemia Working Party
Brissot E., myriam L., domenio r., sonja m., christoph s., bertram g., et al.
American Society of Hematology, 3 - 06 December 2016, (Summary Text)
2016
201683. An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party
Brissot E., Labopin M., Russo D., Martin S., Schmid C., Glass B., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text)
2016
201684. Kronik Myelositer Lösemili Hastalarda İmatinib Tedavisinin Kesilmesi Çok merkezli ileriye dönük bir çalışma
YAĞCI A. M., ÖZKURT Z. N., GÖKÇEN S.
42 Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016, (Summary Text)
2016
201685. Renal Transplantasyon Sonrası Geç Dönemde Gelişen Burkitt Lenfoma Olgusu
TURGUT H., HELVACI Ö., ÖZKURT Z. N., YEGİN Z. A., ERDEM Ö., AKYÜREK N., et al.
18.Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 11 - 15 May 2016, (Summary Text)
2016
201686. Hematolojik Hastalığı Olan Bağışıklığı Baskılanmış Hastalarda Bronkoskopinin Tanısal Etkinliği
KÖKTÜRK N., YILDIRIM F., BAŞARIK AYDOĞAN B., KALKANCI A., GÜZEL TUNÇCAN Ö., AKI Ş. Z., et al.
Türk Toraks Derneği 19. Yıllık Kongresi, Antalya, Turkey, 6 - 10 April 2016, (Summary Text)
2016
201687. ALLOJENEİK KÖK HÜCRE ALICILARINDA GELİŞEN VİRAL HEMORAJİK SİSTİT TEDAVİSİNDE CİDOFOVİR VE LEVOFLOKSASİN’İN ETKİNLİĞİ.
PEPELER M. S., KAYA A., YEGİN Z. A., ÇOLAK M., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., et al.
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 03 March 2016, (Full Text)
2016
201688. Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Pepeler M. S., Yildiz S., Yegin Z. A., Ozkurt Z. N., Tuncan O. G., Erbas G., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51, (Summary Text)
2016
201689. Secondary Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Pepeler M., ÖZKURT Z. N., YILDIZ Z., YEĞİN A., GÜZEL TUNÇCAN Ö., ERBAŞ G., et al.
Hematoloji Kongresi, 1 - 04 March 2016, (Summary Text)
2016
201690. Allojenik kök hücre alıcılarında gelişen viral hemorajik sistit tedavisinde Cidefovir ve Levofloksasin in etkinliği
Kaya a., Yeğin Z., Çolak M., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., Dağlı G.
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 3 - 05 March 2016, (Summary Text)
2015
201591. İmmünsüprese hastalarda gerçek zamanlı polimeraz zincir reaksiyonu Real Time PCR ile polyomavirus DNA pozitifliğinin araştırılması
ÇOLAK M., ALTAY A., ERTEN Y., ÖZKURT Z. N., PINAR A., BOZDAYI G., et al.
3. Ulusal klinik mikrobiyoloji kongresi, Turkey, 18 - 22 November 2015, (Summary Text)
2015
201592. İmmünsüpresif hastalarda EBV enfeksiyonunun Real Time PCR yöntemi ile gösterilmesi
ALTAY A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
3. ulusal klinik mikrobiyoloji kongresi, Turkey, 18 - 22 November 2015, (Summary Text)
2015
201593. Hematolojik maligniteli hastalarda yoğun bakım mortalitesine etkili faktörler
BOYACI N., Güllü Z., ÖZKURT Z. N., YAĞCI A. M., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G.
12. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 4. Avrasya Yoğun Bakım Toplantısı, Ankara, Turkey, 4 - 07 November 2015
2015
201594. Hematolojik maligniteli hastalar için ayrı bir yoğun bakım ünitesi gerekli midir
BOYACI N., Güllü Z., ÖZKURT Z. N., YAĞCI A. M., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G.
12. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, 4. Avrasya Yoğun Bakım Toplantısı, Ankara, Turkey, 4 - 07 November 2015
2015
201595. HEMATOLOJİK MALİNİTELİ İKİ OLGUDA SİSTEMİK SAPROCHAETE CAPİTATA ENFEKSİYONU
AYDIN KAYNAR L., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., KALKANCI A., Ülküden B., PEPELER M. S., et al.
41.Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, pp.139, (Full Text)
2015
201596. Myeloproliferatif Hastalıklarda Tanı Anı Serum SEPCR ve Trombomodulin Düzeylerinin Değerlendirilmesi
çalkaya s., Yeğin Z. A., GÜLBAHAR Ö., ÖZKURT Z. N., ACAR K., Sucak G.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015
2015
201597. Investigation of BK and JC virus DNA positivitiesby real time polymerase chain reaction inimmunosuppressive patients
Çolak M., Altay A., ERTEN Y., ÖZKURT Z. N., PINAR A., BOZDAYI G.
18th Annual Meeting of European Society for Clinical Virology, 9 - 12 September 2015, (Summary Text)
2015
201598. Detection of EBV infection by real time PCRmethod in immunosuppressive patients
Altay A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
18th Annual Meeting of European Society for Clinical Virology, 9 - 12 September 2015, (Summary Text)
2015
201599. Detection of EBV infection by real timePCR method in immunosuppresive patients
Aylin A., Çolak M., DALGIÇ B., ÖZKURT Z. N., FİDAN I., BOZDAYI G.
18th Annual Meeting of the European Society for Clinical Virology, 9 - 12 September 2015
2015
2015100. ACUTE LYMPHOBLASTIC LEUKEMIA IN A PATIENT WITH WERNER SYNDROME
PEPELER M. S., ÖCAL R., YALÇIN M. M., ÜLKÜDEN B., YEGİN Z. A., ÖZKURT Z. N.
5th International Congress on Leukemia Lympoma Myeloma Kongresi, Turkey, 29 April 2015, (Full Text)
2015
2015101. Diagnostic Yield Of Bronchoscopy In The Immunocompromised Patients With Haematological Disorders
Kokturk N., Yildirim F., Aydogan B. B., Kalkanci A., Tunccan Ö., Aki S. Z., et al.
International Conference of the American-Thoracic-Society (ATS), Colorado, United States Of America, 15 - 20 May 2015, vol.191, (Summary Text)
2014
2014102. IS IT POSSIBLE TO PREDICT PULMONARY COMPLICATINOS AND MORTALITY IN HEMATOPOETIC STEM CELL TRANSPLANT RECIPIENTS FROM PRE-TRANSPLANTATION EXHALED NITRIC OXIDE LEVELS?
KÖKTÜRK N., YILDIRIM F., AYDOĞDU M., YEGİN Z. A., ÖZKURT Z. N., SUYANİ E., et al.
3rd Combined WASOGBAL Meeting, 11th WASOG Meeting and 13th International Conference on BAL, İZMİR/KUŞADASI, Turkey, 8 - 11 October 2014, (Summary Text)
2010
2010103. Prognostic value of serum-free light chain monitoring in patients receiving autologous stem cell transplantation
Ozkurt Z. N., Haznedar R., Aki Z., Yagci M., Sucak G. T.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Austria, 21 - 24 March 2010, vol.45, (Summary Text)
2009
2009104. ABNORMAL SERUM FREE LIGHT CHAIN RATIO AS A PREDICTOR OF ADVERSE OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA: HAS THE TIME COME FOR A SIMPLE PROGNOSTIC MARKER?
Yegin Z. A., Yagci M., Ozkurt Z. N., Kursunoglu N., Aki S. Z.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.374, (Summary Text)
2009
2009105. THROMBOPOIETIC CYTOKINES AND PLATELET COUNT IN MULTIPLE MYELOMA
Ozkurt Z. N., Yagci M., Acar K., Sucak G. T., Haznedar R.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.618, (Summary Text)
2009
2009106. CONTRIBUTION OF THALIDOMIDE MAINTENANCE TO LONG TERM RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
Ozkurt Z. N., Haznedar R., Yegin Z. A., Aki S. Z., Ceneli O., Yagci M., et al.
14th Annual Meeting of the European-Hematology-Association, Berlin, Germany, 4 - 07 June 2009, vol.94, pp.387, (Summary Text)
2009
2009107. Vinorelbine and gemcitabine as a salvage regimen prior to stem cell transplantation in refractory or relapse Hodgkin's disease
Aki Z., Sucak G., Yegin A., Ozkurt Z. N., Yagci M.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43, (Summary Text)
2009
2009108. Adverse impact of iron overload on transplant outcome
Sucak G., Yegin Z. A., Ozkurt Z. N., Aki Z., Yagci M.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43, (Summary Text)
2009
2009109. impact of bone marrow fibrosis in the outcome of haematopoietic stem cell transplantation
Sucak G., Suyani E., Aki Z., Akyurek N., Ozkurt Z. N., Altindal S., et al.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, vol.43, (Summary Text)
2008
2008110. The role of pre transplantation serum iron parameters and anti oxidative potential in early posttransplant toxicities
TURKOZ SUCAK G., AKI Ş. Z., PAŞAOĞLU H., ÖZKURT Z. N., YILMAZ-DEMİRTAŞ C., YEGİN Z. A., et al.
13th Congress of the European Hematology Association Copenhagen, Denmark, 12 - 15 June 2008
2008
2008111. THE ROLE OF PRE-TRANSPLANTATION SERUM IRON PARAMETERS AND ANTI-OXIDATIVE POTENTIAL IN EARLY POSTTRANSPLANT TOXICITIES
Sucak G. T., Aki S. Z., Pasaoglu H., Ozkurt Z. N., Demirtas C., Yegin Z. A., et al.
13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.325-326, (Summary Text)
2005
2005112. Relationship of serum adiponectin level, anthropometric parameters and bone mineral density in postmenopausal
Ozkurt B., Ozkurt Z. N., Altay M., Aktekin C., Caglayan O., Tabak Y.
3rd Osteoporosis and Osteoarthritis Congress, Antalya, Turkey, 20 - 24 April 2005, vol.16, pp.2198, (Summary Text)
Books
2023
20231. Lenf nodu muayenesi ve lenfadenopatiye yaklaşım
ÖZKURT Z. N.
in: İç Hastalıklarında anamnez alma ve fizik muayene, Yasemin Tekbudak Erten, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.269-277, 2023
2018
20182. Böbrek hastalılarında hematolojik değişiklikler
ÖZKURT Z. N.
in: HematoLog, Rauf Haznedar, Editor, Galenos, Ankara, pp.69-77, 2018
Funded Projects
2024 - 2027
2024 - 2027A phase 3. two stage randomized, Multicenter, open label study comparing inerdomide daratumumab and dexamethasone versus daratumumab bortesomib and dexamethasone in subject with relapsed refractory multiple myeloma )Excaliber-mm)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2023 - 2027
2023 - 2027Yeni tanı konmuş kronik GVHD olan en az 12 yaşındaki gönüllülerde belumosidil kortikosteroid kombinasyonu ile plasebo kortikosteroid kombinasyonunun etkililiğinin vr güvenliliğinin değerlendirildiği randomize çift kör çok merkezli faz 3 çalışma ( ROCKnROLL)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2023 - 2027
2023 - 2027JAK inhibitörüne relaps refrakter orta 2 veya yüksek risklimyelofibrozhastalarında mevcut en iyi tedavi ile karşılaştırıldığında ımetelstatı değerlendiren randomize açık etiketli faz 3 çalışma
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2023 - 2026
2023 - 2026A retrospective chart review study to evaluate the demographics and treatment patterns of myelofibrosis in routine practice after ruxolutinib approval in turkey (chart mf)
Project Supported by Other Private Institutions
Özkurt Z. N. (Executive)
2022 - 2025
2022 - 2025A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2022 - 2025
2022 - 2025A Phase 2/3 Randomized, Controlled, Open-Label Study of KRT-232 in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post-ET-MF) who are Relapsed or Refractory to Janus Kinase (JAK) Inhibitor Treatment
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2021 - 2025
2021 - 2025Relaps/refrakter Multipl Myelomlu Gönüllülerde Pomalidomid+Bortezomib ve Deeksametazon ile kombinasyonda Belantamab Mafodotinin Etkinliğinin ve Güvenliğinin Değerlendirildiği Faz III Çok Merkezli Açık Etiketki Randomize Çalışma (DREAMM8)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2021 - 2025
2021 - 2025A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2023 - 2024
2023 - 2024Kronik Lenfositik Lösemi Hücrelerinde Dioscinin NLRP3 İnflamazomun İfadelenmesine ve Apoptoza Etkileri
Project Supported by Higher Education Institutions , BAP Other
GÖKÇEN S. (Executive), KAYHAN H., YAĞCI A. M., ÖZKURT Z. N., YEGİN Z. A.
2022 - 2024
2022 - 2024A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kδ Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2017 - 2024
2017 - 2024Transplant için uygun olmayan yeni tanı konmuş multipl miyelom hastalarında, bortezomib (Velcade®), lenalidomid (Revlimid®) ve deksametazon ile kombinasyon halinde isatuksimabın (SAR650984) klinik yararını bortezomib, lenalidomid ve deksametazon ile karşılaştırmalı olarak değerlendiren Faz 3 randomize, açık etiketli, çok merkezli çalışma
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2022 - 2023
2022 - 2023Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2020 - 2023
2020 - 2023A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2)
Industrial Organizations of Other Countries Supported Project
Özkurt Z. N. (Executive)
2020 - 2021
2020 - 2021Ön tanı için yapay zeka destekli kan analiz sistemi
TUBITAK Project , 1507 - TÜBİTAK SME R&D Start Support Program
Sayınalp N.(Executive), Hayran K. M., Özkurt Z. N.
2018 - 2019
2018 - 2019İnvaziv aspergilloz ve kandidoz gelişen kök hücre nakli alıcısı hematolojik maligniteli hastalarda TLR-4, PTX-3, Dectin-1 ve CARD9 genlerindeki tek nükleotid polimorfizmlerinin ve fungal enfeksiyonlara yatkınlığın retrospektif olarak araştırılması
Project Supported by Other Private Institutions
KALKANCI A. (Executive), TUĞ E., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., FİDAN I.
2017 - 2019
2017 - 2019MK-7018, çok merkezli ulusal , gözlemsel ilaç çalışması. Hematolojik malignensisi olan yüksek riskli hastalarda antifungal profilaksi: Uygulamanın klavuzlarla karşılaştırılması
Project Supported by Other Private Institutions
Güzel Tunçcan Ö. (Executive), Metan G.(Executive), Akan H., Ulu Kılıç A., İnkaya A. Ç., Özkurt Z. N., et al.
Activities in Scientific Journals
2019 - Present
2019 - PresentTürkiye’de Lösemi Lenfoma Miyelom Araştırmaları (LLM) dergisi
Advisory Committee Member
Roles in Event Organizations
May 2022
May 20226. Gazi Hematoloji Günleri
Scientific Congress
Yağcı A. M., ÖZKURT Z. N.
Ankara, Turkey
Invited Talks
November 2024
November 2024MDS/MPN Klinisyen Gözü
Conference
50. Ulusal Hematoloji Kongresi-Turkey
November 2023
November 2023VEXAS Sendromu
Conference
Ulusal Hematoloji Kongresi 2023-Turkey
April 2023
April 2023Transplantasyon ilişkili trombotik mikroanjiopati
Conference
Ulısal Kemik iliği Transplantasyonu Kongresi-Turkey
February 2023
February 2023Ulusal standartların tanıtımı ve öz değerlendirme raporu hazırlıkları
Conference
Hematoloji Tıpta Uzmanlık Yeterlilik Kurulu (HEM-TUYEK)-Turkey
November 2022
November 2022Hematoloji Bilim Dalımız/Kliniğimiz Eğitim Programını Akredite Etmek İstiyoruz, Ne yapmalıyız?
Conference
Türk Hematoloji Derneği; 48. Ulısal Hematoloji Kongresi-Turkey
May 2022
May 2022Polistemi Vera
Conference
LLM Derneği; 2. LLM Kongresi-Turkey
March 2022
March 202210th Annual Meet the Experts of Transplanataion an Myeloma EBMT and TCT
Conference
Türk Kemik İliği Vakfı-Turkey
March 2022
March 2022Allo-HKHN Sonrası Nüks AML: Proflaksi, Pre-emptif Yaklaşım ve Tedavi
Conference
Türk Hematoloji Derneği; 14. Ulusal Kök Hücre Kongresi-Turkey
Citations
Total Citations (WOS): 1077
h-index (WOS): 19
Jury Memberships
May-2022
May 2022